Ignite Creation Date:
2024-05-06 @ 6:59 PM
Last Modification Date:
2024-10-26 @ 2:58 PM
Study NCT ID:
NCT05859477
Status:
RECRUITING
Last Update Posted:
2024-01-02
First Post:
2023-05-01
Brief Title:
Nivolumab in Combination With Chemotherapy for FGFR2-positive Metastatic Gastric Cancer
Sponsor:
Kidney Cancer Research Bureau
Organization:
Kidney Cancer Research Bureau
Organization Data
Organization:
Kidney Cancer Research Bureau
Class:
OTHER
Study ID:
NIVOFGFR2
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Kidney Cancer Research Bureau
Lead Sponsor Class:
OTHER
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None